H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 11.9% of adults in Los Angeles have diagnosed diabetes — about even with the U.S. 12% figure. Census population 3,979,576. California Medicare wound biologics: Noridian Healthcare Solutions (JE). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Los Angeles clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Los Angeles storefront.
Orthobiologic Treatments for Your Practice in Los Angeles, CA for clinics & physicians. Compliance support & pricing — contact Hawk Medical.
If a sales sheet cannot tell you that Los Angeles is JE (Noridian Healthcare Solutions) and that adult diabetes here is 11.9% (PLACES 2023), it is selling units, not a program. That is the orthobiologic treatments conversation we actually have.
National Orthobiologic Treatments for Your Practice notes (how the product actually works)13.2% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city of 1M+ with 3,979,576 residents will still mix those payers. CDC PLACES (2023, crude) estimates 11.9% of adults in Los Angeles have diagnosed diabetes — about even with the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Los Angeles trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 11.9% of adults in Los Angeles have diagnosed diabetes — about even with the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 11.9% of adults — about even with the U.S. 12% figure. Obesity is 27.3%; arthritis is 18.8%. That is place-level BRFSS modeling, not a clinic census and not a Los Angeles trial.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what JE reviewers and surveyors expect — not a brochure.
No. Noridian Healthcare Solutions writes coverage. We train staff on documentation patterns those articles already require (wound measurements, conservative care, units). That is support, not a coverage guarantee.
A 510(k)-cleared device has a different regulatory file than a 361 HCT/P. Do not store, bill, or describe them as the same SKU family. Your SOP should split receiving and indication language.
Bring specialty, monthly joint / regenerative volume, and whether you bill JE FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 11.9% diabetes and 18.8% arthritis for Los Angeles — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Los Angeles, CA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Los Angeles is JE geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Los Angeles — about even with the U.S. 12% figure. Planning input, not an outcomes claim.
California Part B wound biologics follow this contractor (siblings: HI, NV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Los Angeles. Useful for joint-program math; still needs a diagnosis and privileging.
No Los Angeles storefront. Joe Bradley is an active practice owner. orthobiologic treatments stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.